Severe hypernatremia in deceased liver donors does not impact early transplant outcome

Transplantation

Volumn 90, Issue 4, 2010, Pages 438-443

  Mangus, Richard S ^a   Fridell, Jonathan A ^a   Vianna, Rodrigo M ^a   Milgrom, Martin L ^a   Chestovich, Paul ^a   Vandenboom, Chelsea ^a   Tector, A Joseph ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Extended criteria donor; Graft survival; Hypernatremia; Orthotopic liver transplant; Transplant outcomes

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; METHYLPREDNISOLONE SODIUM SUCCINATE; RITUXIMAB; SODIUM; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CAUSE OF DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERNATREMIA; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; STEATOSIS;

ADOLESCENT; ADULT; AGED; CADAVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C; HUMANS; HYPERNATREMIA; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS; TREATMENT OUTCOME;

EID: 77955984334     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e764c0     Document Type: Article

References (18)

1. Tector AJ, Mangus RS, Chestovich P, et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006; 244: 439.
2. Mangus RS, Fridell JA, Vianna RM, et al.Nodifferencein clinical transplant outcomes for local and imported liver allografts. Liver Transpl 2009; 15: 640.
3. Avolio AW, Agnes S, Magalini SC, et al. Importance of donor blood chemistry data (AST, serum sodium)inpredicting liver transplant outcome. Transplant Proc 1991; 23: 2451.
4. Gonzalez FX, Rimola A, Grande L, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatol-ogy 1994; 20: 565.
5. Figueras J, Busquets J, Grande L, et al. The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis. Transplantation 1996; 61: 410.
6. Briceno J, Lopez-Cillero P, Rufian S, et al. Impact of marginal quality donors on the outcome of liver transplantation. Transplant Proc 1997; 29: 477.
7. Totsuka E, Dodson F, Urakami A, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: Effect of correction of donor hypernatremia. Liver Transpl Surg 1999; 5: 421.
8. Markmann JF, Markmann JW, Markmann DA, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 2001; 72: 1113.
9. Pokorny H, Langer F, Herkner H, et al. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant 2005; 19: 532.
10. Tekin K, Imber CJ, Atli M, et al.A simple scoring system toevaluate the effects ofcold ischemiaonmarginal liver donors.Transplantation2004; 77: 411.
11. Renz JF, Kin C, Kinkhabwala M, et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 2005; 242: 556.
12. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651.
13. Mangus RS, Tector AJ, Agarwal A, et al. Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and Universityof Wisconsin solution (UW) in adult liver transplantation [see comment]. Liver Transpl 2006; 12: 226.
14. Mangus R, Fridell, JA, Vianna RM, et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl 2008; 14: 365.
15. Mangus RS, Fridell JA, Vianna RM, et al. Use of the piggyback hepa-tectomy technique in liver transplant recipients with hepatocellular carcinoma. Transplantation 2008; 85: 1496.
16. Tector AJ, Fridell JA, Mangus RS, et al. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients. Liver Transpl 2004; 10: 404.
17. Cywinski JB, Mascha E, Miller C, et al. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function. Liver Transpl 2008; 14: 59.
18. Mangus RS, Fridell JA, Vianna RM, et al.Nodifferencein clinical transplant outcomes for local and imported liver allografts. Liver Transpl 2009; 15: 640.